Vivo Ventures VI LLC 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 5:23 pm Sale |
2021-12-31 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Vivo Ventures VI LLC | 139 13.000% |
-55,431 (-99.75%) |
Filing |
| 2021-08-06 4:30 pm Sale |
2021-08-05 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Vivo Ventures VI LLC | 55,570 4.910% |
-4,000 (-6.71%) |
Filing |
| 2021-02-12 4:30 pm Unchanged |
2020-12-31 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Vivo Ventures VI LLC | 59,570 5.500% |
0 (Unchanged) |
Filing |